 |
"We really can't say much about where the [Food and Drug Administration] may be headed under the Bush administration" until a new commissioner is named, says Jeff Trewhitt, spokesperson for the Pharmaceutical Research and Manufacturers of America (PhRMA). But he believes the American public is "pretty comfortable" with current drug standards and procedures, and notes that the drug industry is not seeking major changes to the process. The industry is heartened by the Republican National Committee's party platform, which ...
